{"id":"NCT03854019","sponsor":"The University of Texas Health Science Center, Houston","briefTitle":"Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease","officialTitle":"Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-08-05","primaryCompletion":"2022-11-11","completion":"2022-11-11","firstPosted":"2019-02-26","resultsPosted":"2024-01-05","lastUpdate":"2024-01-05"},"enrollment":20,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Huntington Disease","Irritability"],"interventions":[{"type":"DRUG","name":"Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg)","otherNames":["Nuedexta"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg), then Placebo","type":"EXPERIMENTAL"},{"label":"Placebo, then Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg)","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess efficacy and safety of dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg) in patients with irritability due to Huntington's disease.","primaryOutcome":{"measure":"Irritability as Assessed by The Irritability Scale.","timeFrame":"Baseline","effectByArm":[{"arm":"All Study Participants Pre-Randomization","deltaMin":27.5,"sd":5.8}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":22},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":20},"commonTop":["Insomnia","Headaches","Diarrhea","Fingernail infection","Nausea"]}}